May. 29 Monivent sees MDR process progressing according to plan FW
May. 18 Monivent to continue operations following initial capital sufficiency meeting FW
May. 06 Monivent raises new capital through directed share issues FW
Apr. 30 Monivent reports marginal earnings shift as planned; CEO focuses on regulatory approvals and financing FW
Apr. 30 Monivent AB Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Apr. 27 Monivent balance sheet for liquidation purposes reveals equity shortfall, extraordinary general meeting to be convened FW
Apr. 20 Monivent moved to observation list as expected FW
Apr. 20 Monivent moved to observation list as anticipated FW
Apr. 20 Monivent prepares balance sheet for liquidation purposes - secures bridge loan FW
Apr. 20 Monivent to prepare balance sheet for liquidation purposes - secures bridge loan FW
Apr. 01 Monivent extends bridge loan through end of May FW
Feb. 27 Monivent Narrows Operating Loss in Q4 FW
Feb. 27 Monivent AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
Nov. 18 Monivent Reports Minor Changes in Quarterly Results FW
Nov. 18 Monivent AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-10-10 Monivent Granted First U.S. Patent FW
25-09-19 Monivent Secures SEK 8 Million Bridge Loan to Meet Immediate Capital Needs FW
25-08-29 Monivent Reports Decline in Sales and Revises Financial Targets FW
25-08-29 Monivent AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-25 Monivent Postpones Q2 Report FW
25-07-22 Monivent Granted New Patent in China (Update) FW
25-07-21 Monivent Granted New Patent in China FW
25-05-20 Monivent reduces operating loss FW
25-05-20 Monivent AB Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-23 Major reshuffle in Monivent's Board of Directors, John Haurum becomes new Chairman FW
No results match your criteria